CYGNAL THERAPEUTICS
Live / Registered — Registered (as of 27 Apr 2021)
What this means for you
Registered since 27 Apr 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 27 Apr 2027, and its filing window is open now).
Record
- Serial number
- 87469833
- Registration number
- 6335320
- Mark type
- Word mark
- Filed
- 31 May 2017
- Published for opposition
- 23 Jan 2018
- Registered
- 27 Apr 2021
- Next maintenance filing
- §8 declaration of use, due by 27 Apr 2027 (grace period to 27 Oct 2027)
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer and immune system related diseases
Owner
- Cygnal Therapeutics, Inc., Cambridge, MA, US
- Cygnal Therapeutics, Inc., Cambridge, MA, US
- VL41, Inc., Cambridge, MA, US
- VL41, Inc., Cambridge, MA, US
Prosecution history
- 27 Apr 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 27 Apr 2021 — REGISTERED-PRINCIPAL REGISTER
- 20 Mar 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Mar 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Mar 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 17 Mar 2021 — USE AMENDMENT FILED
- 17 Mar 2021 — TEAS STATEMENT OF USE RECEIVED
- 26 Sept 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Sept 2020 — SOU EXTENSION 5 GRANTED
- 21 Sept 2020 — SOU EXTENSION 5 FILED
- 21 Sept 2020 — SOU TEAS EXTENSION RECEIVED
- 20 Mar 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Mar 2020 — SOU EXTENSION 4 GRANTED
- 18 Mar 2020 — SOU EXTENSION 4 FILED
- 18 Mar 2020 — SOU TEAS EXTENSION RECEIVED